Galon J - Search Results

1

Trial watch: Peptide vaccines in cancer therapy.

Vacchelli E, Martins I, Eggermont A, Fridman WH, Galon J, Sautès-Fridman C, Tartour E, Zitvogel L, Kroemer G, Galluzzi L. Vacchelli E, et al. Among authors: galon j. Oncoimmunology. 2012 Dec 1;1(9):1557-1576. doi: 10.4161/onci.22428. Oncoimmunology. 2012. PMID: 23264902 Free PMC article.

2

Ligands and biological activities of soluble Fc gamma receptors.

Galon J, Bouchard C, Fridman WH, Sautès C. Galon J, et al. Immunol Lett. 1995 Jan;44(2-3):175-81. doi: 10.1016/0165-2478(94)00211-9. Immunol Lett. 1995. PMID: 7797248 Review.

3

Soluble Fc gamma receptors.

Fridman WH, Teillaud JL, Bouchard C, Teillaud C, Astier A, Tartour E, Galon J, Mathiot C, Sautès C. Fridman WH, et al. Among authors: galon j. J Leukoc Biol. 1993 Nov;54(5):504-12. J Leukoc Biol. 1993. PMID: 8228629 Review.

4

Regulation of CD44 isoform expression and CD44-mediated signaling in human dendritic cells.

Haegel-Kronenberger H, de la Salle H, Bohbot A, Galon J, Tartour E, Cazenave JP, Hanau D. Haegel-Kronenberger H, et al. Among authors: galon j. Adv Exp Med Biol. 1997;417:83-90. doi: 10.1007/978-1-4757-9966-8_14. Adv Exp Med Biol. 1997. PMID: 9286342

5

Affinity of the interaction between Fc gamma receptor type III (Fc gammaRIII) and monomeric human IgG subclasses. Role of Fc gammaRIII glycosylation.

Galon J, Robertson MW, Galinha A, Mazières N, Spagnoli R, Fridman WH, Sautès C. Galon J, et al. Eur J Immunol. 1997 Aug;27(8):1928-32. doi: 10.1002/eji.1830270816. Eur J Immunol. 1997. PMID: 9295028

6

A new set of monoclonal antibodies against human Fc gamma RII (CD32) and Fc gamma RIII (CD16): characterization and use in various assays.

Vely F, Gruel N, Moncuit J, Cochet O, Rouard H, Dare S, Galon J, Sautes C, Fridman WH, Teillaud JL. Vely F, et al. Among authors: galon j. Hybridoma. 1997 Dec;16(6):519-28. doi: 10.1089/hyb.1997.16.519. Hybridoma. 1997. PMID: 9455704

7

Soluble Fc gamma receptors: interaction with ligands and biological consequences.

Galon J, Paulet P, Galinha A, Lorès P, Bonnerot C, Jami J, Fridman WH, Sautès C. Galon J, et al. Int Rev Immunol. 1997;16(1-2):87-111. doi: 10.3109/08830189709045704. Int Rev Immunol. 1997. PMID: 9651787 Review.

8

Identification of the cleavage site involved in production of plasma soluble Fc gamma receptor type III (CD16).

Galon J, Moldovan I, Galinha A, Provost-Marloie MA, Kaudewitz H, Roman-Roman S, Fridman WH, Sautès C. Galon J, et al. Eur J Immunol. 1998 Jul;28(7):2101-7. doi: 10.1002/(SICI)1521-4141(199807)28:07<2101::AID-IMMU2101>3.0.CO;2-W. Eur J Immunol. 1998. PMID: 9692878 Free article.

9

Soluble CD16 in plasma cell dyscrasias.

Mathiot C, Galon J, Tartour E, Teillaud JL, Facon T, Bataille R, Fridman WH, Sautès C. Mathiot C, et al. Among authors: galon j. Leuk Lymphoma. 1999 Feb;32(5-6):467-74. doi: 10.3109/10428199909058404. Leuk Lymphoma. 1999. PMID: 10048419 Review.

10

Regulation of production of soluble Fc gamma receptors type III in normal and pathological conditions.

Moldovan I, Galon J, Maridonneau-Parini I, Roman Roman S, Mathiot C, Fridman WH, Sautès-Fridman C. Moldovan I, et al. Among authors: galon j. Immunol Lett. 1999 May 3;68(1):125-34. doi: 10.1016/s0165-2478(99)00041-3. Immunol Lett. 1999. PMID: 10397167 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

236 results

Search Page

Filters